Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis (M11-290)
jRCT2080222598Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Adalimumab with Placebo (2 arms). Started Sep 2014; status: completed.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080222598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222598.